Bio-Techne Fiscal Q4 Revenues Climb 15 Percent

NEW YORK (GenomeWeb) – Bio-Techne said today that its fiscal 2018 fourth quarter revenues were up 15 percent over Q4 2017. On an organic basis, revenues grew 9 percent year over year. 

For the three months ended June 30, the firm reported revenues of $180.3 million compared to $156.6 million in Q4 2017, besting analysts' average estimate of $174.8 million.